ESOU 2019 Prostate Cancer
ESOU 2019: Treatment of Gleason 3+4 in a Multidisciplinary Scenario: Hypofractionation Radiation Therapy
Dr. Bossi started with highlighting for the urologists in the room the dose and fractionation schedule for conventional, moderate and extreme treatment plans:
ESOU 2019: Treatment of Gleason 3+4 in a Multidisciplinary Scenario: Focal Therapy
Dr. Orczyk started by highlighting that Gleason 3+4 disease is truly a multidisciplinary process, even in the focal therapy platform where patients may be candidates for cryosurgery or high-intensity focused ultrasound (HIFU). Dr. Orczyk considers a “target lesion” as having to have the following criteria:
ESOU 2019: Treatment of Gleason 3+4 in a Multidisciplinary Scenario: Active Surveillance
ESOU 2019: An Update in Prostate Cancer Prevention
Several lifestyle factors have been discussed as potential parameters with an impact on prostate cancer risk and prognosis. These have largely been developed based on two robust and impactful recent systematic reviews by the ESOU1,2